About the Authors
- Rosario Diaz
-
Affiliation Instituto de Parasitología y Biomedicina "López-Neyra" Consejo Superior de Investigaciones Cientificas, Granada, Spain
- Sandra A. Luengo-Arratta
-
Affiliations Instituto de Parasitología y Biomedicina "López-Neyra" Consejo Superior de Investigaciones Cientificas, Granada, Spain, Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America
- João D. Seixas
-
Affiliations Instituto de Parasitología y Biomedicina "López-Neyra" Consejo Superior de Investigaciones Cientificas, Granada, Spain, Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America
- Emanuele Amata
-
Affiliation Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America
- William Devine
-
Affiliation Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America
- Carlos Cordon-Obras
-
Affiliation Instituto de Parasitología y Biomedicina "López-Neyra" Consejo Superior de Investigaciones Cientificas, Granada, Spain
- Domingo I. Rojas-Barros
-
Affiliation Instituto de Parasitología y Biomedicina "López-Neyra" Consejo Superior de Investigaciones Cientificas, Granada, Spain
- Elena Jimenez
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Fatima Ortega
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Sabrinia Crouch
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Gonzalo Colmenarejo
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Jose Maria Fiandor
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Jose Julio Martin
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Manuela Berlanga
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Silvia Gonzalez
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Pilar Manzano
-
Affiliation Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain
- Miguel Navarro
-
* E-mail: miguel.navarro@ipb.csic.es (MN); m.pollastri@neu.edu (MPP)
Affiliation Instituto de Parasitología y Biomedicina "López-Neyra" Consejo Superior de Investigaciones Cientificas, Granada, Spain
- Michael P. Pollastri
-
* E-mail: miguel.navarro@ipb.csic.es (MN); m.pollastri@neu.edu (MPP)
Affiliation Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America
Competing Interests
EJ, FO, SC, GC, JMF, JJM, MB, SG, PM are employed by a commercial company, GlaxoSmithKline. This affiliation does not alter our adherence to all the PLOS NTDs policies on sharing data and materials. No other competing interests exist.
Author Contributions
Conceived and designed the experiments: MP MN JJM JMF MB PM. Performed the experiments: RD SALA JDS EA WD CCO DIRB EJ FO SC GC MB SG PM MN MPP. Analyzed the data: RD SALA JDS EA WD CCO DIRB EJ FO SC GC MB SG PM MN MPP. Contributed reagents/materials/analysis tools: MN. Wrote the paper: RD JDS CCO DIRB EJ FO SC GC JMF JJM MB SG PM MN MPP.